New state-of-the-art manufacturing ecosystem will manufacture drugs in several critical therapeutic classes, including cardiovascular, pain and sedation, respiratory, antidote, antiemetic, antibacterial, and anticholinergic. This U.S.-based facility will take 15 drugs completely through the pharmaceutical manufacturing lifecycle, from development to production.